FDA Approves Simbrinza for Glaucoma, Ocular Hypertension

The FDA has approved a suspension of brimonidine and brinzolamide for the reduction of elevated intraocular pressure in patients with primary open-angle glaucoma or ocular hypertension.
FDA Approvals

Full Story →